Serum levels range of myocardial enzymes following urologic procedures.

Not Applicable

Completed

• Conditions: rologic Surgical Procedures; Urologic Surgical Procedures; Renal and Urogenital - Other renal and urogenital disorders; Surgery - Other surgery

• Registration Number: ACTRN12613001071718
• Lead Sponsor: Gennimatas General Hospital of Thessaloniki

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-09-25
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

1. Patients with no medical history of myocardial disease who undergo urologic surgical procedures, including open, endoscopic and laparoscopic surgery.
2. Age over 18 years old.

Exclusion Criteria

1. History of coronary disease.
2. Evidence of acute myocardial infarction (AMI), diagnosed by clinical, laboratory (normal troponin levels) and electrocardiographical findings.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To determine the changes in the levels of CPK (creatine phosphokinase), LDH (lactate dehydrogenase), SGOT (aspartate transaminase) enzymes and CK-MB (creatine phosphokinase MB) isoenzyme in healthy patients who undergo urologic surgery.[The serum activities of CPK, CK-MB, LDH and SGOT are going to be measured preoperatively (the day before surgery) and postoperatively (the first and the third postoperative day).]

Secondary Outcome Measures

Name	Time	Method
To compare the change of these enzymes in separated categories of procedures (open, endoscopic and laparoscopic) [The serum activities of CPK, CK-MB, LDH and SGOT are going to be measured preoperatively (the day before surgery) and postoperatively (the first and the third postoperative day).]